GALECTIN THERAPEUTICS INC's ticker is GALTW and the CUSIP is 363225111. A total of 6 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $7,000 | -65.0% | 125,919 | 0.0% | 0.00% | – |
Q3 2016 | $20,000 | -37.5% | 125,919 | 0.0% | 0.00% | – |
Q2 2016 | $32,000 | -3.0% | 125,919 | 0.0% | 0.00% | – |
Q1 2016 | $33,000 | -63.7% | 125,919 | 0.0% | 0.00% | – |
Q4 2015 | $91,000 | +9.6% | 125,919 | 0.0% | 0.00% | – |
Q3 2015 | $83,000 | -11.7% | 125,919 | +1.5% | 0.00% | – |
Q2 2015 | $94,000 | -36.1% | 124,019 | -2.7% | 0.00% | – |
Q1 2015 | $147,000 | -15.5% | 127,419 | -1.5% | 0.00% | – |
Q4 2014 | $174,000 | -40.8% | 129,300 | -0.3% | 0.00% | – |
Q3 2014 | $294,000 | -75.1% | 129,700 | 0.0% | 0.00% | -100.0% |
Q2 2014 | $1,180,000 | -10.5% | 129,700 | +0.3% | 0.00% | 0.0% |
Q1 2014 | $1,319,000 | +98.9% | 129,300 | -5.6% | 0.00% | 0.0% |
Q4 2013 | $663,000 | -11.6% | 136,900 | -1.4% | 0.00% | – |
Q3 2013 | $750,000 | +331.0% | 138,900 | +1.5% | 0.00% | – |
Q2 2013 | $174,000 | – | 136,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 80,000 | $1,225,000 | 0.28% |
FIRST NEW YORK SECURITIES LLC /NY | 46,100 | $470,000 | 0.23% |
MILLENNIUM MANAGEMENT LLC | 656,600 | $6,697,000 | 0.02% |
Neuberger Berman Group LLC | 129,300 | $1,319,000 | 0.00% |
Tower Research Capital LLC (TRC) | 740 | $8,000 | 0.00% |
Citadel Advisors | 300 | $3,000 | 0.00% |